United States · Series D startup

Who invested in Sera Prognostics

9 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$107Mraised across 9 rounds since 2011, from 9 sources

$1.4MSeries A$19MSeries A$10MGrowth$1.3MVenture$4.5MVenture$9.2MVenture$5.0MSeries B$20MSeries B$36MSeries D
Latest round
Series D, $36MNov 2019
Led by
Blue Ox Healthcare Partners
Step-upi
1.8×
Investors
11 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112013201520172019
$1.4MSeries A$19MSeries A$10MGrowth$1.3MVenture$4.5MVenture$5.0MSeries B$20MSeries B$36MSeries D
First round
Series A, $1.4M
Jan 2011
Biggest round
$36M
Series D · Nov 2019
Usual gap between rounds
10 months
the median of 8

The rounds

  1. Nov 2019
    Series D$36M3 new3 returning

    Reported by FinSMEsSEC filing: $26M sold, first sale Jul 2019

  2. Jan 2015
    Series B$20M5 returning

    From a historical funding recordSEC filing: $5.0M sold, first sale Nov 2014

  3. Nov 2014
    Series B$5.0M3 new1 returning

    From a historical funding recordSEC filing: $5.0M sold, first sale Nov 2014

  4. Jun 2014
    Venture$9.2M

    No investor was named in the report.

    From a historical funding recordSEC filing: $9.2M sold, first sale May 2014

  5. Mar 2014
    Venture$4.5M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.5M sold, first sale Sept 2013

  6. Oct 2013
    Venture$1.3M

    No investor was named in the report.

    Reported by sec.govSEC filing: $1.3M sold, first sale Sept 2013

  7. Nov 2012
    Growth$10M

    No investor was named in the report.

    Reported by sec.govSEC filing: $10M sold, first sale Nov 2011

  8. Nov 2011
    Series A$19M3 new2 returning

    Reported by seraprognostics.comSEC filing: $10M sold, first sale Nov 2011

  9. Jan 2011

Founders and team

From the SEC filings it signed: 3 on the team.

  • Douglas B. FisherExecutive Officeri
  • Gregory C. CritchfieldExecutive Officer, Directori
  • Jay C. MoyesExecutive Officeri

On the board, as filediCharles M. KennedyDennis B. FarrarElizabeth B. CanisJoseph M. SilettoJoshua B. PhillipsKim B. KamdarMansoor M. MirzaMarcus M. WilsonMichael M. MinahanRyan M. Trimble

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Domain AssociatesVC firm4rounds
InterWest PartnersVC firm3rounds
Upstart CapitalInvestment firm2rounds
ChioneVC firm2rounds
Blue Ox Healthcare PartnersPrivate equity1round, led 1
Chione Ltdno record of our own yet1round
Laboratory Corporation of America Holdingsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Sera Prognostics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Vivo CapitalPrivate equityPer its own site
Excelestar VenturesVC firmPer its own site

Quick answers about Sera Prognostics

Who invested in Sera Prognostics?

Sera Prognostics's investors include Domain Associates, InterWest Partners, Catalyst Health Ventures, Catalyst Health & Technology Partners and Upstart Capital, and 6 more on record. Blue Ox Healthcare Partners led its latest round.

How much has Sera Prognostics raised?

Sera Prognostics has raised $107M across 9 rounds since 2011.

When did Sera Prognostics last raise?

Sera Prognostics's most recent round was a Series D of $36M in Nov 2019, led by Blue Ox Healthcare Partners.

What was Sera Prognostics's biggest round?

Its most recent round, $36M in Nov 2019, is also its largest on record.

Who backed Sera Prognostics first?

Sera Prognostics's first round on record, in Jan 2011, was backed by Catalyst Health Ventures and Upstart Capital.

What stage is Sera Prognostics at?

Sera Prognostics's latest named round is a Series D, in Nov 2019.

Where is Sera Prognostics based?

Sera Prognostics is based in the United States.

Who led Sera Prognostics's rounds?

Blue Ox Healthcare Partners led the Series D in 2019.

Companies like Sera Prognostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.